The effect of metalloendoprotease inhibitors on the biochemical differentiation of the rat skeletal muscle line, L6, was investigated. Confluent unfused L6 cells exposed briefly to 1,10-phenanthroline, a chelator of divalent metal cations, or continuously to dipeptide amide metalloendoprotease substrates that are blocked at the NH2-terminals, Ncarbobenzyloxyserylleucyl amide and N-carbobenzyloxyglycylleucyl amide, did not fuse or express creatine kinase, myosin heavy chain, or a-actin. These effects were reversible and dose-dependent. Exposure to N-carbobenzyloxylglycylglycyl amide, which is not a metalloendoprotease inhibitor, had no effect. As the differentiation in a culture progressed, 1,10-phenanthroline became less effective in blocking the accumulation of creatine kinase and myosin heavy chain. Exposure of partially fused cultures to N-carbobenzyloxyseryfleucyl amide prevented any further accumulation of muscle-specific proteins. In confluent cultures where cell division was blocked before the onset of differentiation, N-carbobenzyloxyserylleucyl amide still prevented fusion and the induction of creatine kinase. This indicates that these inhibitors do not act by interfering with the cell cycle. Experiments that measured DNA synthesis rates, plating efficiencies, and the effects ofsequential dipeptide and dimethyl sulfoxide treatments indicate that L6 myoblasts do not irreversibly withdraw from the cell cycle when exposed to N-carbobenzyloxyserylleucyl amide. These results are consistent with the role of a metalloendoprotease in initiating the terminal differentiation of cultured muscle cells.
they begin withdrawing from the cell cycle (Go state) and subsequently lose their proliferative capacity (commitment) (2, 3) . These committed myoblasts then fuse their plasma membranes to form myotubes and biochemically differentiate by synthesizing large amounts of muscle-specific proteins, such as proteins for the contractile apparatus, creatine kinase, and the acetylcholine receptor. These processes result in a terminally differentiated muscle fiber and are collectively referred to as myogenesis. Couch and Strittmatter (4) showed that the metalloendoprotease (MEPr) inhibitors, 1,10-phenanthroline and certain N-carbobenzyloxy dipeptide amides, prevent the Ca2l-dependent fusion of primary rat myoblasts. They identified a MEPr activity in the cytosol of L6 myoblasts that is inhibited by the same compounds that block myoblast fusion (5) . These inhibitors also prevent Ca2+-dependent fusion in vesicle secretory systems (6) , suggesting that MEPrs may have a general role in catalyzing biological membrane fusion.
Our laboratory has recently identified dramatic changes in major plasma membrane glycoproteins during myogenesis of L6 myoblasts. These changes were blocked by the MEPr inhibitors that block fusion (7) . We now report that these same MEPr inhibitors also prevent the increased synthesis of muscle-specific proteins during myogenesis. We hypothesize that a MEPr is involved in initiating the terminal differentiation of L6 myoblasts.
METHODS
Cell Culture. Two subclones of L6, originally isolated by Yaffe (8) , were used: clone A begins fusing 4 to 5 days after plating and is fully fused by day 12, and clone B begins fusing 3 to 4 days after plating becoming fully fused by day 7. Cells were grown on 100-mm, 60-mm, or 35-mm plastic tissue culture dishes (Falcon, Coming) in an 8% CO2 atmosphere at 370C using either Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal calf serum (growth medium) or Ham's F12 medium supplemented with 20% fetal calf serum (nondifferentiating medium). Both contained 1% penicillin/streptomycin (GIBCO).
1,10-Phenanthroline Treatment. Cells grown on 100-mm dishes were washed twice with DMEM and exposed to 10 ml of 80 ,ug of 1,10-phenanthroline monohydrate (Sigma) per ml for 2 hr at 37TC. Controls received an equivalent amount of solvent (0.2% methanol). The dishes were then washed three times with 5 ml of growth medium and -fed- 16 (Fig. 1A , curves b and c) prevented the increase in the rate of creatine kinase accumulation for 1 or 2 days after which creatine kinase accumulated at a rate near that ofthe controls (Fig. 1A, curve d) . Both the decrease in the rate of creatine kinase accumulation and the length of the lag time before recovery were less in those cultures that were more differentiated at treatment (compare curves b and c, Fig. LA) . Exposure of the cells to 0.2% methanol for 2 hr (controls) on 3 successive days delayed the increase in creatine kinase activity only slightly. Confluent unfused cultures that were treated every 2 days with 1,10-phenanthroline remained in the undifferentiated state (Fig. 1A , curve a). Cultures treated three times with 1,10-phenanthroline (80 ,g/ml) remained viable and accumulated creatine kinase activity that was less than 9% of the controls (Fig. 1B) .
The effect of 1,10-phenanthroline on creatine kinase expression was dose-dependent with the half-maximal effect occurring between 10 and 20 ,ug/ml (Fig. 1B) .
Effect of Cbz-Ser-Leu-NH2 on Creatine Kinase Expression. Dipeptides which are blocked at the amino and carboxyl termini and contain hydrophobic carboxyl-terminal residues are substrates and therefore competitive inhibitors of certain MEPrs (15) .
Cbz-Ser-Leu-NH2, a MEPr substrate, has been shown to block myoblast fusion (5) . Continuous exposure of confluent L6 cultures to 750 ,M Cbz-Ser-Leu-NH2 also prevented creatine kinase accumulation ( Fig. 2A , curve a). These cultures did not fuse but remained viable for at least 8 days. When Cbz-Ser-Leu-NH2 was removed from the medium, subsequent fusion and increased creatine kinase activity occurred within 1 day ( Fig. 2A, b) , although the cultures took 3 days to become fully fused. Exposing partially fused cultures to Cbz-Ser-Leu-NH2 resulted in no further increase in creatine kinase activity and a loss of 50% of the specific activity over 3 days (Fig. 2A, c) . Although creatine kinase did not continue to accumulate in partially fused cultures exposed to Cbz-Ser-Leu-NH2, these cultures continued to fuse for approximately another day. Myosin heavy chain content was probed by dot blot immunoassay with a monospecific antibody, and similar results were obtained for both CbzSer-Leu-NH2 and 1,10-phenanthroline (data not shown).
When a sparse population of myoblasts was exposed to 750 AM Cbz-Ser-Leu-NH2, their morphology became dendritic, and some cells became "arborized" (16) . The doubling time of the myoblasts increased to =44 hr compared with 20 hr for control cultures (data not shown). Effect of Cbz-Ser-Leu-NH2 in Cultures of Constant Density.
The biochemical differentiation and fusion of L6 myoblasts has been shown to be density dependent (17) . Furthermore, the density of L6 cultures continues to increase after confluency and the initiation of fusion and differentiation. It was therefore possible that L6 cultures that had been treated with Cbz-Ser-Leu-NH2 did not reach sufficient density to differentiate because of a lengthened generation time.
To answer this question, we required a culture system in which the cell number would remain constant throughout the experiment. Pinset and Whalen (18, 19) showed that L6 myoblasts could be grown to high densities without differentiating or fusing in Ham's F12 medium. Changing the medium to DMEM induced the cultures to differentiate and fuse. When cell division was prevented by inhibitors of DNA synthesis, these cultures still fused and differentiated normally.
We grew L6 myoblasts for 6 days on Ham's F12 medium to a high density. The medium was then changed to DMEM, and the effect of 750 ,M Cbz-Ser-Leu-NH2 on creatine kinase expression was determined. FdUrd (100 ng/ml) was added to the medium to block cell division (20) . Control cultures (Fig. 2B, curve d) began fusing within 24 hr and induced high levels of creatine kinase, whereas those exposed to 750 AM Cbz-Ser-Leu-NH2 continuously (Fig. 2B, curve a) induced only very low levels of the enzyme (<2% of the controls after 5 days). While the majority of dipeptidetreated myoblasts did not fuse, some (<1%) di-nucleated and tri-nucleated myotubes were observed.
When partially fused cultures were exposed to Cbz-SerLeu-NH2 2 or 3 days after switching to DMEM, no further creatine kinase accumulated for up to 3 days, and the specific activity remained essentially constant (Fig. 2B, curves b and  c) . These cultures continued to fuse for another day after this exposure to the dipeptide. However, the newly formed myotubes were elongated and spindly, unlike the amorphous patches observed in untreated cultures. Similar results were obtained when cytosine arabinoside (2 pg/ml) was used in place of FdUrd (data not shown).
Dose Response of Cbz-Ser-Leu-NH2 and Other Dipeptides. The effect of Cbz-Ser-Leu-NH2 on confluent and unfused cultures was dose dependent. The maximal effect on fusion and creatine kinase expression was observed between concentrations of 0.5 mM and 0.75 mM, and the half-maximal effect on creatine kinase expression occurred at about 0.18 mM (Fig. 3, curve a) . With 0.5 mM dipeptide, no creatine kinase activity (<0.5 mU/mg) was detected, although some myotubes were still present. Cbz-Gly-Leu-NH2 is another MEPr substrate that has been shown to block myoblast fusion (4, 5) . It, too, was effective in preventing creatine kinase accumulation in confluent L6 cultures (Fig. 3, curve b ; maximal effect at 1.5 mM and half-maximal effect at about 0.6 mM). Cbz-Gly-Leu-NH2 was also less effective in blocking myoblast fusion compared with Cbz-Ser-Leu-NH2 (4).
Although Cbz-Gly-Gly-NH2 is chemically similar to the other two dipeptides, it is not an inhibitor of MEPrs or myoblast fusion (4, 5) ; it was also ineffective in preventing fusion and creatine kinase accumulation in L6 cultures. At 2 mM Cbz-Gly-Gly-NH2, 90% of the control creatine kinase activity was still present (Fig. 3, c) .
Effect of Cbz-Ser-Leu-NH2 on Other Markers of Muscle Differentiation. Myosin heavy chain and a-actin (muscle actin) are expressed only in differentiated muscle. Nonmuscle-specific ( and y actins are synthesized in both myoblasts and myotubes (21, 22) . It was possible that Cbz-Ser-Leu-NH2 exerted a specific effect on creatine kinase expression but not on biochemical differentiation in general. Therefore, we investigated whether myosin heavy chain and a-actin were expressed in Cbz-Ser-Leu-NH2-treated cells.
L6 cultures were exposed to 750 ,uM Cbz-Ser-Leu-NH2 for 3 days after confluency and then labeled with [35S]methionine for 17 hr. The cells exposed to Cbz-Ser-Leu-NH2 remained mononucleated, while control cells fused to form myotubes. Actomyosin was extracted from the particulate fraction and subjected to NaDodSO4/PAGE. Myosin heavy chain (Mr = 200,000) had been synthesized in the untreated controls but not in the Cbz-Ser-Leu-NH2-treated cultures. Actins (Mr = 42,000) were synthesized in both cultures (Fig. 4A) 750 ,uM Cbz-Ser-Leu-NH2 (lane II) from confluency. The extracts were electrophoresed using NaDodSO4/PAGE on 7% acrylamide gels followed by autoradiography. The figure indicates major bands at 200 kDa and 42 kDa corresponding to myosin heavy chain (MHC) and actins, respectively. (B and C) The total particulate fraction from cultures exposed to 0.1% Me2SO (B) or 750 ,uM Cbz-Ser-Leu-NH2 (C) was prepared and analyzed by isoelectric focusing followed by NaDodSO4/PAGE on 10%6 gels. The acidic region of the gels is at the left; the figure shows the expanded region of the gel where actins (arrow points to a-actin) appear.
actin was not synthesized in the Cbz-Ser-Leu-NH2-treated cultures (Fig. 4C ) but was present in the controls (Fig. 4B,  arrow) .
The pattern of protein synthesis in Cbz-Ser-Leu-NH2-inhibited cultures closely resembles that of fused cultures except for the muscle-specific proteins and several unidentified protein bands (data not shown), indicating that these cells are otherwise normal in protein synthesis.
Effect of Cbz-Ser-Leu-NH2 on Irreversible Withdrawal from the Cell Cycle. Since biochemical differentiation and fusion of L6 cells were inhibited by exposure to Cbz-Ser-Leu-NH2, we investigated whether irreversible withdrawal from the cell cycle (commitment) was also prevented. The results of three types of experiments indicate that Cbz-Ser-Leu-NH2 does prevent commitment in confluent L6 myoblasts.
The effects of 750 ,uM Cbz-Ser-Leu-NH2 on the rate of DNA synthesis were investigated in confluent cultures by measuring the incorporation of [3H]thymidine into cells over a 2-hr period (data not shown). Cultures exposed to the dipeptide from confluency gradually stopped proliferating; by the fourth day of exposure, these cells incorporated only background levels of [3H]thymidine. When the dipeptide was removed from the medium, the rate of DNA synthesis sharply increased and was followed by the initiation of fusion. In a parallel experiment, confluent cells exposed to Cbz-Ser-Leu-NH2 for 4 days had the same plating efficiencies as cells at confluency (77 ± 6% and 76 ± 1%, respectively). Although cells exposed to Cbz-Ser-Leu-NH2 had stopped cycling after 4 days, these cells retained proliferative capacity and were not committed.
Me2SO (2%) inhibits fusion and differentiation in myoblasts by preventing them from leaving the proliferative state (21) . This compound appears to be effective on uncommitted myoblasts only, having little effect on cultures in which a majority of the cells are committed. If Cbz-Ser-Leu-NH2 allows myoblasts to commit, then cells grown first in the presence of Cbz-Ser-Leu-NH2 and then given medium containing 2% Me2SO without the dipeptide would be predicted to fuse and differentiate to the degree that they are committed. Results of such an experiment indicated that Cbz-SerLeu-NH2 prevents commitment of L6 myoblasts (see Table 1 and legend).
DISCUSSION
The effect of MEPr inhibitors on myoblast fusion has been previously studied (4) . However, the previous work did not address whether these compounds inhibited only fusion or the entire process of terminal differentiation. In this study we focused on the effects of MEPr inhibitors on the expression of muscle-specific proteins and the irreversible withdrawal from the cell cycle (commitment) in differentiating L6 myoblasts. We have found that the MEPr inhibitors 1,10-phenanthroline and dipeptide amides blocked at the NH2-terminus prevent the increase in muscle-specific protein expression. Our data also suggest that the dipeptide inhibitor Cbz-Ser-Leu-NH2 prevents commitment of confluent myoblasts. Experiments that measured DNA synthesis rates, plating efficiencies, and the effects of sequential dipeptide and Me2SO treatments indicate that myoblasts exposed to Cbz-Ser-Leu-NH2 stop cycling (enter Go state) but do not lose their proliferative capacity (commit).
Certain differences between the effects of 1,10-phenanthroline and Cbz-Ser-Leu-NH2 on biochemical differentiation are evident. Confluent myoblasts exposed to Cbz-SerLeu-NH2 differentiate more rapidly after removal of the dipeptide than do myoblasts after treatment with phenanthroline. Partially fused cultures exposed to Cbz-Ser-Leu-NH2 do not continue to accumulate creatine kinase or myosin heavy chain, unlike phenanthroline-treated cultures. These differences may be due to the different mechanisms by which these two compounds inhibit MEPrs or to secondary effects elicited by the dipeptides. Cbz-Ser-Leu-NH2 (5) or of 0.1% Me2SO (4) and those previously receiving the dipeptide received either 5 ml of 0.1% Me2SO (2) or 2% Me2SO (3) daily for 4 days. After 3 days, cultures that had been switched to 0.1% Me2SO were fused and expressed creatine kinase activity (2, 4) . The culture exposed first to Cbz-Ser-Leu-NH2 for 4 days, followed by 2% Me2SO for 4 days (3), was unfused and expressed creatine kinase only 2% of the control. After 4 days in the presence of Cbz-Ser-Leu-NH2, the majority of the myoblasts must have been uncommitted, because 2% Me2SO prevented them from fusing and differentiating. As expected, myoblasts exposed to 2% Me2SO, then Cbz-Ser-Leu-NH2, also neither fused nor differentiated (5) . Cbz-Ser-Leu-NH2 does not act by interfering with the cell-cycle. Under those conditions in which undifferentiated cultures of confluent myoblasts were induced to differentiate in the absence of cell division (prevented by FdUrd) (19, 20) , Cbz-Ser-Leu-NH2 still prevented the accumulation of creatine kinase. When these cultures were allowed to partially fuse and then exposed to Cbz-Ser-Leu-NH2, the specific activity of creatine kinase remained constant for 3 days. When dipeptide treatment of partially fused cultures was performed in normal growth media, creatine kinase specific activity was reduced by 50%o over 3 days. We have routinely observed the detachment of myotubes from fusing cultures and the subsequent replacement with dividing myoblasts. Therefore, this reduction in creatine kinase specific activity may be due to a loss of existing myotubes that were not replaced because of dipeptide inhibition of fusion and differentiation. When FdUrd was present in the media, the loss of myotubes in fusing cultures was considerably reduced.
The requirement for an endogenous MEPr in myoblast fusion has been proposed previously (4) . In this study we showed that the same MEPr inhibitors that prevent fusion (4) had similar effects on biochemical differentiation. For example, Cbz-Ser-Leu-NH2 was more potent than Cbz-Gly-Leu-NH2 in both respects, and Cbz-Gly-Gly-NH2, was ineffective in blocking both fusion and biochemical differentiation in L6 myoblasts. Also, the concentrations of dipeptides and phenanthroline that inhibited differentiation were similar to those required to inhibit fusion (4) and the endogenous MEPr activity (5) in L6 myoblasts. Therefore, evidence for the role of a MEPr in initiating the terminal differentiation of cultured myoblasts is convincing.
Terminal differentiation in muscle is a complex multistep process, the biochemical details of which have yet to be elucidated. In recent years, however, evidence has accumulated that indicates the temporal relationships between the cell cycle, commitment, fusion, and induction of musclespecific genes. A minimal scheme proposing the relationships of the main events of terminal differentiation, which is consistent with the experimental data (3, 20, 21, (23) (24) (25) (26) (27) also a probability that these Go cells will take the pathway of differentiation (20) -the cells will lose their proliferative capacity irreversibly (commitment), fuse, and induce musclespecific genes (gene induction). The paths that lead to fusion and gene induction have been shown to be independent (23) (24) (25) (26) (27) . Recent studies using myoblast cell lines that are temperature sensitive for commitment (25) or cells grown in media with low free Ca2" (24) indicate that gene induction can occur in the absence of commitment and fusion and that genes are deinduced upon reentry into the cell cycle. Thus, free Ca2+ is required for commitment and fusion but not for gene induction.
Our results indicate that in the presence of the MEPr inhibitor Cbz-Ser-Leu-NH2, confluent L6 myoblasts enter the Go state but do not fuse, commit, or express musclespecific proteins. Therefore, we propose that a MEPr activity is required for the transition from the Go state to a state we designate as Go'. Cells which have reached the Go' state are able to reversibly induce muscle-specific genes, but an additional Ca2+-dependent step is required for commitment and subsequent fusion. If a MEPr activity is involved in the transition from Go to Go', then inhibiting this activity should prevent myoblasts from undergoing commitment, fusion, and biochemical differentiation. Although the scheme indicates only one site of action for a MEPr, our data do not rule out the possibility that other stages of differentiation might also require MEPr activity.
The effect of MEPr inhibitors on gene induction does not appear to be specific to fusing myoblasts. BC3H1 is a smooth muscle-like cell line derived from mouse (28) that undergoes reversible gene induction upon withdrawal of growth factors or serum from the medium but that does not fuse to form myotubes (29, 30) . Our preliminary studies indicate that Cbz-Ser-Leu-NH2 prevents creatine kinase induction in BC3H1 as well. Therefore, the involvement of MEPrs in cellular differentiation may be a general phenomenon rather than being specific to L6 myoblasts.
